1. |
Nielsen JB, Crone C, Hultborn H. The spinal pathophysiology of spasticity—from a basic science point of view. Acta Physiol (Oxf), 2007, 189(2): 171-180.
|
2. |
Centers for Disease Control and Prevention. What is cerebral palsy? [EB/OL]. [2024-03-03]. https://www.cdc.gov/ncbddd/cp/facts.html.
|
3. |
Brashear A, Elovic E. Spasticity: diagnosis and management. 2nd ed. New York: Demos Medical Publishing, 2011: 10-11.
|
4. |
Wissel J, Manack A, Brainin M. Toward an epidemiology of poststroke spasticity. Neurology, 2013, 80(3 Suppl 2): S13-S19.
|
5. |
|
6. |
Rodda J, Graham HK. Classification of gait patterns in spastic hemiplegia and spastic diplegia: a basis for a management algorithm. Eur J Neurol, 2001, 8 Suppl 5: 98-108.
|
7. |
|
8. |
|
9. |
|
10. |
|
11. |
|
12. |
|
13. |
Collado H, Bensoussan L, Viton JM, et al. Does fascicular neurotomy have long-lasting effects? J Rehabil Med, 2006, 38(4): 212-217.
|
14. |
|
15. |
|
16. |
|
17. |
|
18. |
|
19. |
|
20. |
|
21. |
Daniels L, Worthingham C. Muscle testingtechniques of manual examination. 4th ed. Philadelphia, London, Toronto: W. B. Saunders Company, 1980: 72-74.
|
22. |
|
23. |
|
24. |
|
25. |
|
26. |
|
27. |
Deltombe T, Lejeune T, Gustin T. Botulinum toxin type A or selective neurotomy for treating focal spastic muscle overactivity? Ann Phys Rehabil Med, 2019, 62(4): 220-224.
|
28. |
|
29. |
|
30. |
Preston DC, Shapiro BE. Electromyography and neuromuscular disorders: clinical-electrodiagnostic-ultrasound correlations. 4th ed. Canada: Elsevier, 2020: 194-196.
|